Anti-ageing compound developed biotech & biosciences |17 February 2017| Russia Russian scientists have slowed the ageing process in mice using an artificial antioxidant. Genetically-modified mice treated with small doses of the SkQ1 compound were slower to age than the control group who were given none. Unlike the control group, who aged rapidly – as expected, the typical traits of aging (osteoporosis, alopecia, thinning of skin) in the treated mice was dramatically decelerated. Moscow State University biologist, Professor Vladimir Skulachev, the creator of SkQ1 molecule design and co-author of this study, said the “study opens the way to the treatment of ageing”. He is now developing a set of pharmaceuticals based on SkQ1 molecule, with the development of an oral form in the pipeline – if approved “anti-ageing” drug can be approved for systemic indications in 2-3 years. The joint study undertaken by scientists from Lomonosov Moscow State University and Stockholm university study was published in the US journal Aging.